Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report.

Stelmach, Iwona; Sztafinska, Anna; Woicka-Kolejwa, Katarzyna; Jerzynska, Joanna

Stelmach, Iwona; Sztafinska, Anna; Woicka-Kolejwa, Katarzyna; Jerzynska, Joanna.

Afiliación

Stelmach I; Department of Pediatrics and Allergy, Medical University of Lodz, Poland. Head: Prof. Iwona Stelmach MD, PhD.
Sztafinska A; Department of Pediatrics and Allergy, Medical University of Lodz, Poland. Head: Prof. Iwona Stelmach MD, PhD.
Woicka-Kolejwa K; Department of Pediatrics and Allergy, Medical University of Lodz, Poland. Head: Prof. Iwona Stelmach MD, PhD.
Jerzynska J; Department of Pediatrics and Allergy, Medical University of Lodz, Poland. Head: Prof. Iwona Stelmach MD, PhD.

Postepy Dermatol Alergol ; 31(3): 191-3, 2014 Jun.

Article en En | MEDLINE | ID: mdl-25097493

Palabras clave

anaphylaxis; asthma; immunotherapy; omalizumab; prophylaxis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Postepy Dermatol Alergol Año: 2014 Tipo del documento: Article